Pembrolizumab Plus Platinum-Doublet Chemotherapy and Concurrent Radiotherapy as First-Line Treatment for Unresectable, Locally Advanced Stage III NSCLC: The KEYNOTE-799 Trial in Perspective

Intratumoral Dendritic Cells in Treatment of Lung Cancer

Comprehensive Analysis of Proteomics Identifies New, Druggable Drivers of NSCLC—and New Avenue for Continued Research

The eNRGy1 Global Multicenter Registry: NRG1 Fusions as a Hidden Target in Lung Cancer

Question Literature’s Face Value

Gemcitabine: A New Chemotherapy Partner for Immune Checkpoint Inhibitors? Insights From the ORIENT-12 Study

Telehealth Struggles to Find Permanent Footing After Rapid Growth During Pandemic

Therapeutic Vaccine Development in Lung Cancer: Update and Recent Advances

Economics of Locally Advanced Lung Cancer Before and During COVID-19 Pandemic: A Perspective for Developing Countries

Ablation Techniques for Lung Nodules: Percutaneous or Transbronchial Approach?

Dr. Patrick Forde Discusses Excitement Around Neoadjuvant Immunotherapy for Lung Cancer

Addition of Nivolumab to Neoadjuvant Chemotherapy in NSCLC: Results of CheckMate-816